Revenue Comparison
Chart: Revenue Comparison. Values in USD_BILLIONS. In Q2 2026: Amgen 10.054, Roche 17.5245.
* Roche reports semi-annually. Values are evenly split across both quarters within each half.
Amgen vs Roche: Revenue Comparison
Amgen (AMGN) and Roche (RHHBY) are peers in GLP-1. Amgen reported revenue of $10.1B as of Q2 2026, compared with $35.0B for Roche. Roche leads on revenue.
Amgen's gross margin is 72.0% versus 73.7% for Roche. Amgen's net margin is 23.6% versus 22.6% for Roche.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, Amgen, Roche.| Metric | Amgen | Roche |
|---|---|---|
| Market Cap | - | - |
| Revenue | $10.05B | $35.05B |
| Cost of Revenue | $2.81B | $9.21B |
| Gross Profit | $7.24B | $25.84B |
| Operating Income | $3.51B | $10.90B |
| Net Income | $2.38B | $7.93B |
| R&D Expense | $1.87B | $8.35B |
| Earnings Per Share | $4.37 | $1.23 |
| Gross Margin | 72.0% | 73.7% |
| Operating Margin | 35.0% | 31.1% |
| Net Profit Margin | 23.6% | 22.6% |
| Free Cash Flow | $3.49B | $6.46B |
| Cumulative Free Cash Flow | $169.18B | $305.80B |
| Operating Cash Flow | $4.00B | $8.28B |
| Cash & Equivalents | $13.99B | $6.13B |